3-iodobenzylguanidine has been researched along with Demyelinating Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atak, F; Aydın, GB; Oğuz, KK; Öncel, İ; Öz, S | 1 |
1 other study(ies) available for 3-iodobenzylguanidine and Demyelinating Diseases
| Article | Year |
|---|---|
Rhombencephalitis and longitudinal extensive myelitis associated with dinutuximab use in high-risk neuroblastoma.
Topics: 3-Iodobenzylguanidine; Antibodies, Monoclonal; Child, Preschool; Demyelinating Diseases; Female; Hematopoietic Stem Cell Transplantation; Humans; Myelitis; Neuroblastoma; Transplantation, Autologous | 2023 |